Recro Pharma, Inc.
(NASDAQ : REPH)

( )
REPH After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -16.36%57.710.0%$1537.44m
GILDGilead Sciences, Inc. -0.22%73.181.0%$1287.43m
AMGNAmgen, Inc. -1.78%222.401.3%$637.47m
REGNRegeneron Pharmaceuticals, Inc. -4.33%545.212.5%$616.99m
NVAXNovavax, Inc. 4.47%48.17102.0%$608.66m
VRTXVertex Pharmaceuticals, Inc. -6.48%266.501.9%$516.32m
BIIBBiogen, Inc. -2.84%295.871.6%$413.02m
ILMNIllumina, Inc. -0.08%354.413.5%$354.75m
SRNESorrento Therapeutics, Inc. 3.95%5.271.8%$307.06m
SGENSeattle Genetics, Inc. -2.59%151.736.1%$243.04m
ALXNAlexion Pharmaceuticals, Inc. 1.28%102.802.0%$224.06m
AAgilent Technologies, Inc. 1.37%86.141.6%$196.15m
CODXCo-Diagnostics, Inc. -2.80%18.030.0%$185.93m
MGNXMacroGenics, Inc. -6.82%23.646.2%$178.27m
BMRNBioMarin Pharmaceutical, Inc. 6.39%103.744.3%$172.63m

Company Profile

Recro Pharma, Inc. is a pharmaceutical company, which engages in the contract development and manufacturing organization (CDMO). It offers solutions for the development, formulation, regulatory support, manufacturing, and packaging of oral solid dose drug products. The company was founded by Geraldine A. Henwood and Thomas F. Henwood on November 15, 2007 and is headquartered in Malvern, PA.